Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

Peer Review reports

Original Submission
12 Aug 2009	Submitted	Original manuscript
3 Sep 2009	Reviewed	Reviewer Report - Holger Thiele
10 Sep 2009	Author responded	Author comments - Youlan Gu
Resubmission - Version 2
10 Sep 2009	Submitted	Manuscript version 2
Publishing
28 Sep 2009	Editorially accepted
28 Sep 2009	Article published	10.1186/1745-6215-10-90

Back to article page